IL1B and myalgic encephalomeyelitis/chronic fatigue syndrome: Treatment with CFS from strain M6 resulted in a reduction of histopathological lesions and IL-1β expression characterized by inflammatory cell infiltration in the dermis and subcutaneous layer (Fig. 5e, g and Supplementary Fig. 6b).